ISB News

ISB Post Doc Gets Patent for Protein that Blocks HIV

MartinShelton
Martin Shelton

Martin Shelton, a post doc in the Lee Hood lab, just received his first patent. He shared the following explanation with his 10-year-old nephew who’s a burgeoning scientist/inventor/engineer.

“We made a small molecule called a peptide (which is a sciency word for a piece of a protein). This peptide blocks a function that is key to the spread of the Human Immunodeficiency Virus (HIV, the virus that causes AIDS) within a person by trapping the virus within the infected cell and preventing it from infecting surrounding cells. It knocks out a similar function in cancer that could hinder tumor growth and the spread of cancer from one part of the body to another. We think it could one day be used to help treat HIV/AIDS or cancer, but it still has a long way to go and would have to pass many, many more tests before it could be used as a medicine. But in the meantime, it’s a useful tool for studying certain aspects of these diseases.”

Congratulations, Martin!

20130502-184513.jpg

Recent Articles

  • ISB Associate Professor Dr. Sean Gibbons

    ‘1 in 1,000:’ Dr. Sean Gibbons Named Highly Cited Researcher for 2023

    ISB Associate Professor Dr. Sean Gibbons was named a Highly Cited Researcher for 2023. It is the second consecutive year Gibbons has earned the distinction. The Highly Cited Research list is generated annually by Clarivate, which says: “Of the world’s population of scientists and social scientists, Highly Cited Researchers are 1 in 1,000.”

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on.

  • Breakthrough T Cell Discovery Has Huge Potential for Engineering Custom Immune Responses

    In a breakthrough discovery that changes how we understand T cells and with implications of how we can better engineer custom immune responses to fight disease, Institute for Systems Biology researchers showed that the different disease-fighting functions of different T cells are determined by the genetically encoded T-cell receptor sequence that are unique to those cells.